Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00281788 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | completed | Phase 1 | 13 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | completed | Phase 2 | 50 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00686465 | Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study(PETREC) | completed | N/A | 101 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00002625 | Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 5 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004127 | Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 35 | University of ChicagoOTHER | 2 | Feb 11, 2013 | clinicaltrials |
| NCT01776346 | Barrett's Esophagus Patient Registry(BPR) | unknown | — | 750 | Massachusetts General HospitalOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00722605 | Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer | completed | Phase 1 / Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00061958 | Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00002930 | PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery | completed | Phase 2 / Phase 3 | 75 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004879 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00650988 | Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers | completed | Early Phase 1 | 37 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00525200 | p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer(PANCHO) | completed | Phase 3 | 170 | Daniela KandiolerOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00003076 | Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus | completed | Phase 2 | 152 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00509561 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | unknown | Phase 2 / Phase 3 | 259 | Wales Cancer Trials UnitOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01341197 | Fecal Screening Assay for Taiwanese Population | completed | — | 3,172 | National Taiwan University HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01243398 | Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy | completed | Phase 3 | 450 | University of OxfordOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01391208 | Esophageal Protocol for Detection of Neoplasia in the Digestive Tract | completed | Phase 1 | 25 | University of MichiganOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT01688700 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT00025532 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00798746 | Quality of Life After Esophagectomy for Cancer | completed | — | 88 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00006081 | Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00505024 | Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery | completed | N/A | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00502502 | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients | completed | — | 205 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT01640860 | Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal Cancer | completed | — | 36 | Chonnam National University HospitalOTHER | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00368329 | Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer | terminated | Phase 1 | 4 | Stanford UniversityOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01630174 | IMRT/Pemetrexed/Cisplatin in Esophageal Cancer | unknown | — | 30 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT01038544 | Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal Cancer(CT0003) | completed | N/A | 50 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00012363 | S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus | completed | Phase 2 | 61 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00445861 | Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 27 | Swiss Cancer InstituteOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00072033 | Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | completed | Phase 2 | 66 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00238407 | Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 21 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | completed | Phase 1 / Phase 2 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT01605305 | Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 60 | Fudan UniversityOTHER | 0 | May 24, 2012 | clinicaltrials |
| NCT00520091 | Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | completed | Phase 2 | 14 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT00017212 | DX-8951f in Treating Patients With Metastatic Stomach Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 2 | May 16, 2012 | clinicaltrials |
| NCT01203163 | Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes(CALIPSO) | withdrawn | — | 0 | Pinnacle Biologics Inc.INDUSTRY | 0 | May 9, 2012 | clinicaltrials |
| NCT00753844 | Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer | completed | Phase 1 | 7 | Kinki UniversityOTHER | 1 | Apr 6, 2012 | clinicaltrials |
| NCT01054274 | a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent | unknown | Phase 3 | 180 | Southeast University, ChinaOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT01175447 | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer | completed | Phase 1 | 12 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | completed | Phase 1 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT00585741 | Pilot Study of 18F-FLT PET | terminated | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00900094 | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer(IRB 2000-294) | completed | — | 200 | University of Michigan Rogel Cancer CenterOTHER | 0 | Feb 7, 2012 | clinicaltrials |
| NCT01525953 | Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis(CRCRT-EC) | completed | — | 110 | Centre Oscar LambretOTHER | 1 | Feb 3, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Mar 21, 2013source: clinicaltrials